DNA X (SONM) Q1 2026 earnings summary

Executive summary

• Completed sale of legacy phone and hotspot business to NEXA for $15 million on January 23, 2026, with $12 million received immediately and $1.5 million due in October 2026, shifting focus to AI-driven crypto trading platform.

• Rebranded as DNA X, Inc. and transitioned all phone and hotspot operations to NEXA, exiting legacy business.

• Platform enables automated trading strategies and is expanding features and supported cryptocurrencies in 2026.

• Revenue now primarily from trading commissions; legacy hardware business results classified as discontinued operations.

• Generated $6.3 million net income in Q1 2026, primarily from the asset sale.

Financial highlights

• Net income for Q1 2026 was $6.3 million, up from $0.5 million in Q1 2025, driven by a $15.6 million pre-tax gain on asset sale.

• Net loss from continuing operations was $3.9 million in Q1 2026, compared to $1.0 million in Q1 2025.

• Net revenues from discontinued operations were $3.8 million for Q1 2026, down from $16.7 million in Q1 2025 due to the asset sale.

• General & administrative expenses from continuing operations were $3.6 million, including $1.5 million in severance and $0.9 million in professional services.

• Cash and cash equivalents at March 31, 2026, were $1.2 million; agreement to raise an additional $1.8 million via new debt.

Outlook and guidance

• $1.8 million in new financing expected to fund operations through December 31, 2026; additional capital may be needed if note is not converted.

• Plans to launch an enhanced AI trading platform to the public later in 2026.

• Focus on expanding trading platform features and increasing trading volume and commission revenue.

• Expects general & administrative expenses to decrease in coming quarters due to downsizing and audit completion.

• Substantial doubt exists regarding ability to continue as a going concern if additional capital is not raised.